
CVS Cuts 2024 Profit Forecast as Medical Care Drives Costs Higher
CVS Health lowered its adjusted profit forecast for 2024 on Wednesday after an increase in medical procedures among older adults in the United States fueled costs in its insurance business in the fourth quarter. The company beat Wall Street estimates for fourth-quarter profit, however, on strength in its drugstores and its pharmacy benefits management (PBM) unit, which negotiates drug prices between insurers and manufacturers. Its shares rose over 3 percent to $76.26 in morning trading. The healthcare conglomerate, like rival Humana earlier, cited a late-year rise in medical care due to outpatient procedures among those enrolled in Medicare Advantage plans. Under those plans, the government pays insurers to manage healthcare for people 65 and older, or those with disabilities....
